Immunologic analysis of a phase I/II study of vaccination with MAGE-3 protein combined with the AS02B adjuvant in patients with MAGE-3-positive tumors.

Source:http://linkedlifedata.com/resource/pubmed/id/14770084

Download in:

View as

General Info

PMID
14770084